Goldman Sachs Knock-Out PGR/ DE000GG536U8 /
| 2024-06-05 9:39:50 PM | Chg.+0.02 | Bid10:00:41 PM | Ask10:00:41 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.71EUR | +1.18% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 194.6009 USD | 2078-12-31 | Call |
GlobeNewswire
6:00 PM
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six M...
GlobeNewswire
3:00 PM
The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening
GlobeNewswire
2:30 PM
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
2:05 PM
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and...
GlobeNewswire
12:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
8:00 AM
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
GlobeNewswire
06-04
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...
GlobeNewswire
06-04
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire
06-03
MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...
GlobeNewswire
05-31
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire
05-30
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
05-30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
05-29
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...
GlobeNewswire
05-28
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
05-28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
05-28
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
05-25
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
05-24
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire
05-24
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
